Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.95 USD | -0.25% | +10.11% | -8.20% |
May. 31 | Prelude Therapeutics Files for $400 Million Mixed Shelf | MT |
May. 07 | Prelude Therapeutics Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.20% | 218M | |
+49.14% | 56.95B | |
+39.98% | 40.26B | |
-7.33% | 39.32B | |
-4.42% | 28.37B | |
+12.17% | 26.45B | |
-18.03% | 19.41B | |
+29.54% | 12.54B | |
+25.83% | 12.21B | |
-1.33% | 12.15B |
- Stock Market
- Equities
- PRLD Stock
- News Prelude Therapeutics Incorporated
- Transcript : Prelude Therapeutics Incorporated Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-12-2023 04